Sign in

CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company

CalciMedica, Inc.

Sign in to watch
Ticker
CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452120079
Phone
858-952-5500
Business address
505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
Former names
CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
  1. 4/A Open-market buy Chief Executive Officer bought 1,000 shares at $5.23 ($5,225)
  2. 8-K Event Regulation FD disclosure
  3. CERT Other Certification
  4. 8-A12B Other Registration of Securities
  5. 8-K Event Regulation FD disclosure
  6. 4 Open-market buy Director bought 714 shares at $5.20 ($3,713)
  7. 4 Open-market buy Chief Business Officer bought 485 shares at $5.20 ($2,522)
  8. 4 Open-market buy Chief Executive Officer bought 1,328 shares at an average $5.23 ($6,951)
  9. 4 Open-market buy Director bought 1,000 shares at an average $5.04 ($5,040)
  10. 4 Open-market buy Chief Business Officer bought 4,700 shares at an average $5.13 ($24,118)
  11. 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $5.19 ($10,377)
  12. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.80 ($4,800)
  13. 4/A Open-market buy Chief Executive Officer bought 1,000 shares at $2.70 ($2,698)
  14. 4 Open-market buy Chief Business Officer bought 3,687 shares at an average $4.64 ($17,096)
  15. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.21 ($4,210)
  16. 4 Open-market buy Director bought 255 shares at an average $4.14 ($1,055)
  17. 4 Open-market buy Chief Business Officer bought 2,000 shares at $3.86 ($7,723)
  18. 4 Open-market buy Director bought 500 shares at $3.27 ($1,634)
  19. 4 Open-market buy Chief Executive Officer bought 3,000 shares at $3.34 ($10,032)
  20. 4 Open-market buy Chief Business Officer bought 8,000 shares at an average $3.03 ($24,226)

Page 15 of 27 · 533 filings